ScholarIQanswers from OpenAlex & ORCID
Nancy Paul Roc
ResearcherPublications, citations & collaboration network
Nancy Paul Roc is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Nancy Paul Roc have?
ScholarIQindexed works
Nancy Paul Roc has 9 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Nancy Paul Roc have?
ScholarIQcitation count
Nancy Paul Roc has 24 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Nancy Paul Roc?
ScholarIQh-index
Nancy Paul Roc has an h-index of 1 in OpenAlex.
What is the i10-index of Nancy Paul Roc?
ScholarIQi10-index
Nancy Paul Roc has an i10-index of 1 in OpenAlex.
What is the OpenAlex record for Nancy Paul Roc?
ScholarIQopenalex
The OpenAlex for Nancy Paul Roc is on the source record.
What are the most-cited papers on Nancy Paul Roc?
ScholarIQmost cited works
Early access for innovative oncology medicines: a different story in each nation
Tara Cowling, Ransi Nayakarathna, Allison Wills, Dipti Tankala, Nancy Paul Roc, Stéphane Barakat
The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab
Kimberly Guinan, Karine Mathurin, Jean Lachaîne, Nancy Paul Roc, Sarah-Jane Bull, Dipti Tankala, Stéphane Barakat, Beenish S. Manzoor, Christopher Hillis, Versha Banerji
The Economic Impact of Treatment Sequencing in the Management of Chronic Lymphocytic Leukemia in Canada Using Venetoclax Plus Obinutuzumab
Kimberly Guinan, Jean Lachaîne, Nancy Paul Roc, Sarah-Jane Bull, Dipti Tankala, Stéphane Barakat, Christopher Hillis, Versha Banerji
Costs of Healthcare Resource Utilization in the Management of Patients with Higher-Risk Myelodysplastic Syndrome in Canada
Kimberly Guinan, Laurie Demers-Rozon, Monika Ham, Yoann Brassard, Nancy Paul Roc, Paola Lembo, Grace Christou, Christopher Lemieux, Stéphane Barakat, Yanqing Xu, Mathieu Pelletier, Jean Lachaîne
Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience
Chakrapani Balijepalli, Lakshmi Gullapalli, Swati Prasad, Nancy Paul Roc, Ana Rusu, Natalia Price, W. J. Dempster, Stéphane Barakat